What does this research mean for the field?

Early administration of the lipid-lowering drug lovastatin halts the progression of early atherosclerosis in the carotid artery and significantly reduces the risk of major ischemic vascular events, including stroke. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the efficacy of lovastatin alone or combined with warfarin in preventing the 3-year progression of carotid intimal-medial thickness and reducing vascular events in mild atherosclerosis.

April 28, 1995Cerebrovascular Diseases

Effect of Cholesterol-Lowering Medications on Progression of Mild Atherosclerotic Lesions of the Carotid Arteries and on the Risk of Stroke

View Full Paper

Ask AI

Bookmark

Why the study?

Does lovastatin alone or in combination with warfarin prevent 3-year progression of mean maximum intimal-medial thickness in men and women aged 40-79 with moderately elevated LDL cholesterol and early carotid atherosclerosis?

Key Points

To evaluate the efficacy of lovastatin alone or combined with warfarin in preventing the 3-year progression of carotid intimal-medial thickness and reducing vascular events in mild atherosclerosis.
Factorial, placebo-controlled trial enrolling 919 men and women aged 40–79 years with moderately elevated LDL cholesterol and baseline carotid intimal-medial thickness of 1.5–3.5 mm.
Assessed changes in mean maximum intimal-medial thickness and cardiovascular outcomes over a 3-year treatment period.
Mean maximum carotid intimal-medial thickness declined by 0.009 mm/year in lovastatin-treated participants compared to an increase of 0.006 mm/year in controls (p = 0.001).
Lovastatin significantly lowered all-cause mortality and the combined incidence of coronary deaths, nonfatal myocardial infarctions, and strokes.
All 5 strokes observed during the trial occurred exclusively in participants receiving lovastatin placebo.

Structured PICO

Population

919 men and women aged 40–79 who had moderately elevated low-density-lipoprotein (LDL) cholesterol and a single maximum IMT of 1.5–3.5 mm in the carotid arteries

Intervention

Lovastatin alone or in combination with warfarin

Comparator

Lovastatin placebo

Outcome

3-year progression of mean maximum intimal-medial thickness (IMT)surrogate

Early administration of lovastatin halts the progression of early atherosclerosis in the carotid artery and may lessen the risk of ischemic vascular events including stroke.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports early statin use in moderate LDL with early carotid disease; confirms IMT slowing on imaging in RCTs.

Cite This Study

Adams et al. (1995) studied this question.

synapsesocial.com/papers/6a1bcdd301af05bf0da8f277 https://doi.org/10.1159/000107847

Topics

Statin therapy

View Full Paper

Ask AI

Bookmark

Effect of Cholesterol-Lowering Medications on Progression of Mild Atherosclerotic Lesions of the Carotid Arteries and on the Risk of Stroke

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Effect of Cholesterol-Lowering Medications on Progression of Mild Atherosclerotic Lesions of the Carotid Arteries and on the Risk of Stroke

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider